GBGonzalo Barreix

Gonzalo Barreix

*This is an algorithmically generated author record based on publicly available information.

Gonzalo Barreix has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Associations Between Social Assistance Benefit Adequacy and Poverty-Related Infectious Diseases: A Longitudinal Study of 51 Low- and Middle-Income Countries

    by Gabriel Alves de Sampaio Morais, Ana Wieczorek Torrens, Gonzalo Barreix, Elisa Landin-Basterra, Natanael J. Silva, Davide Rasella

    Background: Social assistance is a core policy strategy for reducing poverty and protecting vulnerable populations, yet cross-country evidence on the association between benefit adequacy and the burden of major poverty-related infectious diseases remains limited. We aimed to evaluate the association between social assistance benefit adequacy and the incidence and mortality of HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases (NTDs) across low- and middle-income countries (LMICs).Methods: This longitudinal study combined country-level panel data on social assistance from the World Bank and poverty-related infectious disease incidence and mortality from the Global Burden of Disease (GBD) for 51 LMICs from 2000 to 2019. We used multivariable fixed-effects negative binomial panel regression models to estimate the associations between social assistance benefit adequacy and disease-specific incidence and mortality, adjusted for all relevant demographic, socioeconomic, and health-related covariates. We also assessed heterogeneity according to sex and age groups.Findings: A 10-percentage-point increase in social assistance benefit adequacy was associated with a 7.2% reduction in HIV/AIDS incidence (incidence rate ratio [IRR] = 0.9275, 95% confidence interval [CI]: 0.9016–0.9530), a 6.0% reduction in tuberculosis incidence (IRR = 0.9397, 95% CI: 0.9284–0.9521), an 8.3% reduction in malaria incidence (IRR = 0.9163, 95% CI: 0.8899–0.9435), and a 2.0% reduction in NTD incidence (IRR = 0.9812, 95% CI: 0.9724–0.9900). Benefit adequacy was associated with 2.0% lower tuberculosis mortality (IRR= 0.9812, 95% CI: 0.9694–0.9930) and 15.5% lower malaria mortality (IRR= 0.8441, 95% CI: 0.8179–0.8711), while no significant associations were observed for HIV/AIDS mortality (IRR= 1.0020, 95% CI: 0.9821–1.0232) or NTD mortality (IRR= 0.9980, 95% CI: 0.9841–1.0131). Stratified analyses by sex generally followed the patterns observed in the overall population, while among children under five, protective associations were observed across all outcomes.Interpretation: Social assistance could contribute to reducing the burden of major infectious diseases of poverty. Our findings suggest that policy attention should extend beyond programme coverage to the adequacy of benefits provided. Ensuring adequate levels of support may strengthen disease-control efforts in LMICs by reducing poverty and improving the socioeconomic conditions that shape infectious disease risk, while advancing progress towards the Sustainable Development Goals on ending poverty and the epidemics of major infectious diseases.Funding: Spanish Ministry of Science and Innovation.

  • Open Access

    Mitigating the Effects of Humanitarian and Development Assistance Defunding on Child Mortality and Undernutrition in 62 Low-and Middle-Income Countries: An Integrated Retrospective and Forecasting Study of 11.2 Million Child-Years over three decades (2002-2035)

    by Courtney Sciarratta, Gabriela dos Santos de Jesus, Peter Kirwan, Hugo Santa, Andréa Ferreira da Silva, Natanael J. Silva, Elisa Landin-Basterra, Audrey Claire Benson, Gonzalo Barreix, Nuria Botella, et al.

    Background. Concerns have been raised about the potential negative consequences of recent large scale reductions in Official Development Assistance (ODA) funding to lower-and-middle-income-countries (LMICs). This study aimed to comprehensively evaluate the impact of ODA funding on under-five (U5) mortality and undernutrition over the past two decades, and to assess the potential health effects of alternative mitigation strategies in response to current ODA defunding trends, including donors meeting the target of 0.7% of gross national income (GNI) for ODA and the short-term reallocation of debt-related payments. Methods. We conducted an integrated retrospective evaluation and forecasting analysis using longitudinal individual-level data from 62 LMICs during 2002–2035, comprising 11.2 million child-years. First, we estimated the associations between ODA per capita and U5 mortality, wasting, stunting, and other healthcare outcomes using two-way fixed-effects multivariable Poisson regression models with robust standard errors, adjusted for all relevant demographic, socioeconomic, and health-system covariates. We then assessed heterogeneity according to sex, area of residence, and wealth level, and conducted sensitivity and triangulation analyses to evaluate the robustness and causal interpretation of the findings. Finally, we integrated the retrospective estimates into calibrated dynamic microsimulation models to project U5 mortality and undernutrition outcomes through 2035 under different ODA funding scenarios. Findings. Higher ODA funding levels were associated with 26% lower U5 mortality (incidence rate ratio (IRR) 0.74; 95% confidence interval (CI) 0.70-0.78), 47% lower prevalence of severe U5 stunting (prevalence ratio (PR) 0.53; 95% CI 0.50-0.57), and 65% lower prevalence of severe U5 wasting (PR 0.35; 95% CI 0.29-0.41). They were also associated with a 55% higher prevalence of births delivered in a medical facility (PR 1·55; 95% CI 1·53–1·58), a 49% higher prevalence of antenatal care (ANC) initiation in the first trimester (PR 1·49; 95% CI 1·44–1·54), and a 34% higher prevalence of eight or more ANC visits (PR 1·34; 95% CI 1·21–1·49). Associations were stronger in rural areas and lower-income groups. Over 2027-2035 in the selected 62 LMICs, an estimated 2.11 million (95% uncertainty interval (UI): 0.61–3.55 million) U5 deaths were averted in the debt-interest reallocation scenario, 3.84 million (1.83–5.72 million) in the debt service scenario, and 4.55 million (2.46–6.57 million) in the donor GNI 0.7% scenario. Corresponding estimates of averted stunting and wasting case-years were 46.3 million (36.0-57.0 million) and 27.4 million (19.0-36.4 million) for debt-interest reallocation, respectively; 92.9 million (78.0-109.0 million) and 53.2 million (39.3-67.6 million) for debt-service reallocation; and 106.1 million (93.0-119.3 million) and 54.0 million (43.8-65.1 million) for the donor GNI 0.7% scenario. Interpretation. Higher ODA funding has played a decisive role in reducing avoidable child mortality and undernutrition across LMICs over the past two decades. The abrupt withdrawal of this support threatens to undermine this progress and impose a substantial health burden on children worldwide. Conversely, mitigation policies involving increased donor funding and the short-term reallocation of debt-related payments could avert millions of child deaths and cases of undernutrition over the next decade.

  • Open Access

    The Impact of Achieving Universal Social Protection on Under-5 Mortality in 37 Low- and Middle-Income Countries: An Integrated Retrospective and Forecasting Study of 7.7 Million Child-Years, 2000–2035

    by Elisa Landin, Davide Rasella, Audrey Claire Benson, Peter D. Kirwan, Natanael Silva, Libor Šulc, Gonzalo Barreix, Lucas de Oliveira Ferreira de Sales, Rodrigo Anderle, Andréa Ferreira Silva

    Background: Universal social protection (USP) is increasingly recognised as a key strategy for reducing poverty and health inequalities. Our study aims to evaluate the impact of expanding comprehensive social protection (SP) on under-5 mortality across low- and middle-income countries (LMICs) over the past two decades, and to forecast the effects of achieving USP compared with scenarios of SP deterioration. Methods: This retrospective impact evaluation integrated with forecasting analyses, used individual-level longitudinal data comprising 3.1 million child-years between 2000 and 2019 from 37 LMICs. We fitted two-way fixed-effects multivariable Poisson regression models with robust standard errors to estimate the effects of SP expansion on under-5 mortality, while assessing effect heterogeneity and performing extensive sensitivity and triangulation analyses. We subsequently integrated the retrospective data and effect estimates into validated dynamic microsimulation models based on 4.6 million child-years to forecast outcomes through 2035. Findings: A 10-percentage-point increase in SP coverage was associated with a 2·2% reduction in under-5 mortality (IRR:0·80;95%CI:0·70–0·92) between 2000 and 2019. The associations were stronger among children aged 1–4 years (IRR:0·54;95%CI:0·38–0·78), in rural populations (IRR:0·78;95%CI:0·67–0·90), and in low-income countries (IRR:0·67;95%CI:0·58–0·78). We estimated that observed SP expansion over the two-decade study period could have averted 3·34 million child deaths (95%CI:1·22–5·46). Forecasting analyses projected that achieving USP by 2035 could avert 2.46 million child deaths (95%UI:0·92–3·83) across the LMICs under study. Conversely, declines in SP coverage could lead to 1.00 million additional avoidable child deaths (95%UI:0·35–1·59). Interpretation: Achieving USP, as envisaged by target 1.3 of the 2030 Agenda for Sustainable Development, could substantially reduce child mortality in LMICs. Conversely, reduction in existing SP coverage due to declining development assistance and increasing fiscal austerity could result in substantial numbers of avoidable child deaths.

  • Open Access

    Effects of Humanitarian and Development Assistance Defunding from Major European Donors on Mortality in 130 Low-And Middle Income Countries

    by Hugo-Alejandro Santa-Ramírez, Núria Botella, Peter D. Kirwan, Claudia García-Vaz, Gonzalo Barreix, Jorge Rivera, David McNair, Ariel Nhacolo, Ivalda Macicame, Quique Bassat, et al.

    Background: Recent reductions in Official Development Assistance (ODA) have raised concerns about their potential impact on health in low- and middle-income countries (LMICs). We aimed to assess the impact of reductions in ODA from 11 major donor European countries on mortality in LMICs through 2030.Methods: We conducted a modelling study using country-level data on ODA disbursements and published estimates of the association between ODA and mortality. We estimated changes in averted deaths using the preventable fraction of the population under two scenarios: a reference scenario in which ODA funding is maintained at previous peak levels, and a reduction scenario based on recent declines and projected trends through 2030. Uncertainty intervals were derived using Monte Carlo simulations. Results: ODA disbursements varied across donor countries and over time, with heterogeneous timing of peak funding and subsequent reductions. Reductions in ODA were associated with decreases in potential averted deaths across all donors. The largest estimated excess deaths under the reduction scenario, compared with the reference scenario, were observed for the United Kingdom (4,304,844 additional deaths [95% Uncertainty Intervals - UI: 1,673,595–6,840,258]), followed by France (3,017,695 [95%UI:1,271,946–4,771,584]) and Germany (2,823,230 [95%UI:1,242,110–4,394,089]). Findings were consistent across modelling approaches. Interpretation: Reductions in ODA from European donors may translate into millions of avoidable deaths in LMICs by 2030, even if funding stabilizes over the coming years. These findings underscore the importance of sustained humanitarian and development assistance and highlight the toll of abrupt funding cuts.

  • Open Access

    Introduction to Quantitative Health Impact Assessment

    by Davide Rasella, Daniella Medeiros Cavalcanti, Andréa Ferreira da Silva, Rodrigo Volmir Rezende Anderle, Gonzalo Barreix Sibils, Vanessa Gorasso, Brecht Devleesschauwer